feed,title,long_url,short_url
Benzinga,Iovance's Lifileucel Shows Meaningful Increase in Response Time with Primary Anti-PD-1 Resistance in Melanoma Trial,https://benzinga.com/general/biotech/21/06/21446189/iovances-lifileucel-shows-meaningful-increase-in-response-time-with-primary-anti-pd-1-resistance-,https://j.mp/3x6kx9V
